Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Neurogranin ELISA Kit (AC2868)
Cat.#: ASET-1457
Specifications
Description Human Neurogranin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Neurogranin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.42 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2044 Human NRG2 ELISA Kit (AC3455) Quantitative inquiry ASET-1695 Mouse Wnt6 ELISA Kit (AC3106) Quantitative inquiry ASET-2532 Rabbit beta Nerve Growth Factor ELISA Kit (AC3943) Quantitative inquiry ASET-1560 Rat Cathepsin B ELISA Kit (AC2971) Quantitative inquiry ASET-1011 Rat PTN ELISA Kit (AC2422) Quantitative inquiry ASET-1443 Human NPY5R ELISA Kit (AC2854) Quantitative inquiry ASET-1788 Human MAN2B1 ELISA Kit (AC3199) Quantitative inquiry ASET-1625 Human TDP43 ELISA Kit (AC3036) Quantitative inquiry ASET-1428 Sheep Myelin Basic Protein ELISA Kit (AC2839) Quantitative inquiry ASET-1725 Human NPEPPS ELISA Kit (AC3136) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket